The Effect of Color Therapy on Depression, Stress, Anxiety and Quality of Life in Hemodialysis Patients: A Randomized Controlled Study

NCT ID: NCT06879808

Last Updated: 2025-03-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-01

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was conducted to examine the effect of color therapy on depression, stress, anxiety and quality of life in hemodialysis patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Many patients on hemodialysis treatment require hemodialysis, which requires hospitalization three times a week for four hours each dialysis session. Therefore, practices such as color therapy may be useful in the management of psychological symptoms in these patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodialysis Color Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomization; participants were divided into two groups by using simple random numbers table, and then the first group which was drawn by lot method was named as the experimental group.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Color therapy group

group doing color therapy

Group Type EXPERIMENTAL

Color therapy

Intervention Type OTHER

In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.

No color therapy group

group not doing color therapy

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Color therapy

In the experimental group, color therapy was applied 3 days a week for the first two weeks, while no intervention was performed in the third and fourth weeks. In the fifth and seventh weeks, color therapy was applied for 15 minutes each day, while no intervention was performed in the sixth week.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be on hemodialysis treatment for at least 6 months,
* No sleeping pills or sedative medication,
* No physical or cognitive impairment that prevents them from understanding the education and no diagnosis of a psychiatric illness,
* The patient or someone living in the same household with the patient is literate,
* Patients have no vision problems,
* Patients must be 18 years of age or older.

Exclusion Criteria

* Being on hemodialysis treatment for less than 6 months,
* Taking sleeping pills or sedative medication,
* Being diagnosed with a physical illness or cognitive impairment or psychiatric illness that prevents understanding the education provided,
* Illiteracy of the patient and relatives,
* Patients have vision problems,
* Refusing to participate in the research,
* Under 18 years of age
Minimum Eligible Age

18 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erzincan Binali Yildirim Universitesi

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Safiye Yanmış

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gülcan Bahçecioğlu Turan, Associate Professor

Role: PRINCIPAL_INVESTIGATOR

Firat University

Zülfünaz Özer, Associate Professor

Role: STUDY_DIRECTOR

Istanbul Sebahattin Zaim University

Safiye Yanmış, Assistant Professor

Role: STUDY_DIRECTOR

Erzincan Binali Yildirim Universitesi

Mukadder Mollaoğlu, Professor Doctor

Role: STUDY_DIRECTOR

Cumhuriyet University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fırat University

Elâzığ, Merkez, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Scientific Research Projects

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

Erzi̇ncanBinaliYildirimUni

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.